Details of the Drug Reposition

General Information of This Drug (ID: DMZAL7W)

Drug Name
Promazine   DMZAL7W
Synonyms
Ampazine; Berophen; Esparin; Liranol; Prazin; Prazine; Promazin; Promazina; Promazinum; Promwill; Propazinum; Protactyl; Romtiazin; Sinophenin; Tomil; Verophen; Combelen [veterinary]; Promazina [Italian]; A 145; RP 3276; WY 1094; Combelen [veterinary] (TN); Neo-Hibernex; Promazina [INN-Spanish]; Promazine (INN); Promazine [INN:BAN]; Promazinum [INN-Latin]; Sparine (TN); Wy-1094; N-(3-Dimethylaminopropyl)phenothiazine; N-Dimethylamino-1-methylethyl thiodiphenylamine; Dimethyl(3-phenothiazin-10-ylpropyl)amine; N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine; N,N-dimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine; 10-(3-(Dimethylamino)propyl)phenothiazine; 10-[3-(Dimethylamino)propyl]phenothiazine; 10H-Phenothiazine-10-propanamine, N,N-dimethyl-(9CI); 10H-Phenothiazine-10-propanamine, N,N-dimethyl-, monohydrochloride
Therapeutic Class
Antipsychotic Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
7 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Disruptive behavior disorder DIS5ACCI N.A. Approved [1]
Angioedema DIS90QDN 4A00.15 Approved [1]
Acute intermittent hepatic porphyria DIS80J7E 5C58.11 Approved [1]
Psychotic disorder DIS4UQOT 6A20-6A25 Approved [1]
Allergic rhinitis DIS3U9HN CA08.0 Approved [1]
Urticaria DIS9WQAI EB00-EB05 Approved [1]
Vomiting DISDOA71 MD90 Approved [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Allergic conjunctivitis DISZ5ZJN 9A60.02 Withdrawn [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Schizophrenia DISSRV2N 6A20 Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------
2 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pruritus DISVH62W EC90 Investigative [1]
Psychomotor agitation DISWSSQH MB23.M Investigative [4]
------------------------------------------------------------------------------------

References

1 Promazine FDA Label
2 Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
3 Persistent Pulmonary Hypertension of the Newborn
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015